相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Crosstalk between adipokines and myokines in fat browning
A. Rodriguez et al.
ACTA PHYSIOLOGICA (2017)
Circulating irisin levels as a predictive biomarker for sarcopenia: A cross-sectional community-based study
Jae Seung Chang et al.
GERIATRICS & GERONTOLOGY INTERNATIONAL (2017)
Irisin regulates cardiac physiology in zebrafish
Lakshminarasimhan Sundarrajan et al.
PLOS ONE (2017)
Irisin prevents and restores bone loss and muscle atrophy in hind-limb suspended mice
Graziana Colaianni et al.
SCIENTIFIC REPORTS (2017)
Irisin and musculoskeletal health
Graziana Colaianni et al.
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES (2017)
Inhibition of myostatin in mice improves insulin sensitivity via irisin-mediated cross talk between muscle and adipose tissues
J. Dong et al.
INTERNATIONAL JOURNAL OF OBESITY (2016)
Structural and electrical cardiac abnormalities are prevalent in asymptomatic adults with myotonic dystrophy
Preeti Choudhary et al.
HEART (2016)
Association between circulating irisin and insulin resistance in non-diabetic adults: A meta-analysis
Shanhu Qiu et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2016)
The role of sex, adiposity, and gonadectomy in the regulation of irisin secretion
M. Zuegel et al.
ENDOCRINE (2016)
Myotonic dystrophies: An update on clinical aspects, genetic, pathology, and molecular pathomechanisms
Giovanni Meola et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2015)
Detection and Quantitation of Circulating Human Irisin by Tandem Mass Spectrometry
Mark P. Jedrychowski et al.
CELL METABOLISM (2015)
Irisin is associated with osteoporotic fractures independently of bone mineral density, body composition or daily physical activity
Andrea Palermo et al.
CLINICAL ENDOCRINOLOGY (2015)
Gonadal failure is associated with visceral adiposity in myotonic dystrophies
Elena Passeri et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2015)
Development and Validation of a New Molecular Diagnostic Assay for Detection of Myotonic Dystrophy Type 2
Rea Valaperta et al.
GENETIC TESTING AND MOLECULAR BIOMARKERS (2015)
Irisin is more strongly predicted by muscle oxidative potential than adiposity in non-diabetic men
Claire Huth et al.
JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY (2015)
The myokine irisin increases cortical bone mass
Graziana Colaianni et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Muscle wasting in myotonic dystrophies: a model of premature aging
Alba Judith Mateos-Aierdi et al.
FRONTIERS IN AGING NEUROSCIENCE (2015)
Irisin and Myonectin Regulation in the Insulin Resistant Muscle: Implications to Adipose Tissue: Muscle Crosstalk
Luis Gamas et al.
JOURNAL OF DIABETES RESEARCH (2015)
Leptin administration activates irisin-induced myogenesis via nitric oxide-dependent mechanisms, but reduces its effect on subcutaneous fat browning in mice
A. Rodriguez et al.
INTERNATIONAL JOURNAL OF OBESITY (2015)
Circulating Irisin Levels Are Positively Associated with Metabolic Risk Factors in Sedentary Subjects
Mara Moreno et al.
PLOS ONE (2015)
Connecting Myokines and Metabolism
Rexford S. Ahima et al.
ENDOCRINOLOGY AND METABOLISM (2015)
Longitudinal Variation of Circulating Irisin After an Energy Restriction-Induced Weight Loss and Following Weight Regain in Obese Men and Women
Ana B. Crujeiras et al.
AMERICAN JOURNAL OF HUMAN BIOLOGY (2014)
Irisin and FGF21 Are Cold-Induced Endocrine Activators of Brown Fat Function in Humans
Paul Lee et al.
CELL METABOLISM (2014)
Irisin stimulates muscle growth-related genes and regulates adipocyte differentiation and metabolism in humans
J. Y. Huh et al.
INTERNATIONAL JOURNAL OF OBESITY (2014)
Effects of obesity, diabetes and exercise on Fndc5 gene expression and irisin release in human skeletal muscle and adipose tissue: in vivo and in vitro studies
Timea Kurdiova et al.
JOURNAL OF PHYSIOLOGY-LONDON (2014)
Irisin in patients with nonalcoholic fatty liver disease
Stergios A. Polyzos et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2014)
Circulating irisin is associated with osteoporotic fractures in postmenopausal women with low bone mass but is not affected by either teriparatide or denosumab treatment for 3 months
A. D. Anastasilakis et al.
OSTEOPOROSIS INTERNATIONAL (2014)
Exercise-mimicking treatment fails to increase Fndc5 mRNA & irisin secretion in primary human myotubes
Timea Kurdiova et al.
PEPTIDES (2014)
Association of Irisin with Fat Mass, Resting Energy Expenditure, and Daily Activity in Conditions of Extreme Body Mass Index
Maria Pardo et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2014)
Irisin Is Expressed and Produced by Human Muscle and Adipose Tissue in Association With Obesity and Insulin Resistance
Jose Mara Moreno-Navarrete et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Vitamin D, parathyroid hormone and muscle impairment in myotonic dystrophies
E. Passeri et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2013)
Identification and Characterization of DM1 Patients by a New Diagnostic Certified Assay: Neuromuscular and Cardiac Assessments
Rea Valaperta et al.
BIOMED RESEARCH INTERNATIONAL (2013)
A role for PLCβ1 in myotonic dystrophies type 1 and 2
Irene Faenza et al.
FASEB JOURNAL (2012)
Cardiac manifestations of myotonic dystrophy type 1
Helle Petri et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2012)
The myotonic dystrophies: molecular, clinical, and therapeutic challenges
Bjarne Udd et al.
LANCET NEUROLOGY (2012)
A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis
Pontus Bostroem et al.
NATURE (2012)
FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise
Joo Young Huh et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2012)
REGIONAL BODY COMPOSITION AND FUNCTIONAL IMPAIRMENT IN PATIENTS WITH MYOTONIC DYSTROPHY
Lelia Pruna et al.
MUSCLE & NERVE (2011)
Physiopathological mechanism of sarcopenia
Y. Boirie
JOURNAL OF NUTRITION HEALTH & AGING (2009)
Ribonuclear inclusions and MBNL1 nuclear sequestration do not affect myoblast differentiation but alter gene splicing in myotonic dystrophy type 2
Rosanna Cardani et al.
NEUROMUSCULAR DISORDERS (2009)
Type 2 myotonic dystrophy can be predicted by the combination of Type 2 muscle fiber central nucleation and scattered atrophy
Guillaume Bassez et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2008)
PREFERENTIAL CENTRAL NUCLEATION OF TYPE 2 MYOFIBERS IS AN INVARIABLE FEATURE OF MYOTONIC DYSTROPHY TYPE 2
Valerio Pisani et al.
MUSCLE & NERVE (2008)
Cardiac and skeletal muscle involvement in myotonic dystrophy type 2 (DM2):: A quantitative 31P-MRS and MRI study
C Schneider-Gold et al.
MUSCLE & NERVE (2004)
Histopathological differences of myotonic dystrophy type 1 (DM1) and PROMM/DM2
A Vihola et al.
NEUROLOGY (2003)
Assessment of a disease-specific muscular impairment rating scale in myotonic dystrophy
J Mathieu et al.
NEUROLOGY (2001)
分享论文
